• An independent Drug Information & Research Center (DIRC) registered with International Registry of Drug Information Service (IRDIS)
  • It has been providing unbiased drug information to healthcare professionals including Students and professional pharmacists and the medical practitioners
  • The highlight of this service is that even the lay public too has been seeking information on various aspects of medication and to sort out their doubts and confusion
  • The DIRC is communicating the vital information on medicines through SMS, Facebook and through email to the Registered Pharmacists

How to avail the Drug information service

  • Pass on your queries either over phone (080-46729800 (100 line)/ 23383142 / 23404000) extn:7/8 or by mail: or by post / courier to office address with your contact details
  • The DIRC pharmacist will call you back for any additional information required and the Drug information will be passed on to you by e-mail / telecon

This service is provided free of cost to the doctors, pharmacists, students, patients and the general public

Books and Reference Guides


Lung Injury

FDA Warns Public to stop Using Tetrahydrocannabinol (THC)-Containing vaping products and any vaping products obtained off the street.

Read More

Continuing Pharmacy Education Program (CPE) for Community and Hosptial Pharmacist

Karnataka State Pharmacy Council in association with D.R. Karigowda College of Pharmacy & Karnataka Registered Pharmacists Association, Hassan is conducting one day Continuing Pharmacy Education Program for Community & Hospital Pharmacist on 5th October 2019 at D.R. Karigowda College of Pharmacy, Hassan. For registration contact Dr. Meena Purohit, Principal, 7760585096

Read More

Fluoroquinolones Antibiotics Associated With Risk Of Heart Problems

Researchers found that current users of fluoroquinolone antibiotics, such as Ciprofloxacin or Cipro, face a 2.4 times greater risk of developing aortic and mitral regurgitation, where the blood back flows into the heart, compared to patients who take amoxicillin, a different type of antibiotic.

Read More

FDA approves Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib

The U.S. Food and Drug Administration has approved new warnings about an increased risk of blood clots and of death with the 10 mg twice daily dose of tofacitinib which is used in patients with ulcerative colitis.

Read More

Continuing Pharmacy Education Program (CPE) for Community & Hospital Pharmacists

Karnataka State Pharmacy Council in association with B.L.D.E.A SSM College of Pharmacy and Research Centre, Vijayapura is conducting one-day Continuing Pharmacy Education Program (CPE) for Community & Hospital Pharmacist on 20th July 2019 at BLDEA’s SSM College of Pharmacy & Research Center, Vijayapura. For Registration Contact Dr. S. M. Biradar, Organizing Chairman, Mob: 9481872333

Read More

Drug Safety Alerts - Pharmacovigilance Programme of India (PvPI)

The preliminary analysis of Serious Unexpected Serious Adverse Reaction (SUSARs) from the PvPI database reveals that the following drugs are associated with the risks as given below.

Read More

Drug of the Quarter - Sacubitril + Valsartan

Reduce the risk of cardiovascular death and hospitalisation for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction.

Read More


The centre provides unbiased drug information to meet the needs of the practicing physicians, pharmacists and other health care professionals. Drug Information Centre work towards in promotion of safe, effective, rational and economic use of drugs by the health professionals and patients.

  • Drug Therapy Guidance
  • Evaluation of Adverse Drug Reactions
  • Evaluation of Drug Interactions
  • Drug Administration, route, admixtures Identification of equivalents for foreign brands
  • Designing Dosage schedules
  • Toxicology
  • Patient Counseling
  • Continuing Education Programme

News and Events

KSPC released the first issue of DIC Newsletter in October 1999. The eight-page bulletin carries information on the activities of drug information & rationale use of drugs, commonly asked enquiries and invited articles from experts from healthcare—specifically pharmaceutical domain. The bulletin is designed for local use within the pharmacy and medical community. One page in every issue is dedicated to articles in Kannada. The DIC newsletter is a member of International Society of Drug Bulletins (ISDB)

Read More

Contact Us


Mobile No.

E-mail ID